Aplasia Cutis Congenita in a Baby born to Hyperthyroid Mother Treated with Methimazole During Pregnancy: A Case Report.
- Author:
Myo Jing KIM
1
;
Mi Jin KIM
;
Gyu Rang CHO
;
Hee Won CHUEH
;
Jin A JUNG
;
Young Souk LEE
;
Young Hoon KIM
;
Jae Ho YOO
Author Information
1. Department of Pediatrics, College of Medicine, Dong-A University, Busan, Korea. pedendo@dau.ac.kr
- Publication Type:Case Report
- Keywords:
Aplasia cutis congenita;
Methimazole
- MeSH:
Ectodermal Dysplasia;
Humans;
Hyperthyroidism;
Infant, Newborn;
Methimazole;
Mothers;
Parturition;
Pregnancy;
Scalp;
Skin
- From:Journal of Korean Society of Pediatric Endocrinology
2008;13(1):100-103
- CountryRepublic of Korea
- Language:Korean
-
Abstract:
Aplasia cutis congenita is a rare congenital anomaly characterized by focal absence of skin at birth. It most commonly manifests as a solitary defect on the scalp, but sometimes it may occur as multiple lesions. Frieden classified aplasia cutis congenita into nine types according to the associated anomalies, but a unifying theory has not been identified to explain the etiology of this disease. We report a case of a newborn with isolated aplasia cutis congenita on the scalp at birth, whose mother was treated with methimazole up to the 22 weeks of gestation due to hyperthyroidism.
